http://www.medpagetoday.com
PHILADELPHIA -- Antibiotic resistance is a growing problem in modern medicine, but few new antimicrobial drugs are coming down the pipeline -- for both economic and regulatory reasons, as experts discuss in this InFocus™ segment.
Link to this comment:
All Comments (0)